{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:52:08Z","timestamp":1791337928306,"version":"4.3.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although maintenance dialysis (MD) affects only a small proportion of patients with tuberculosis (TB), individuals receiving dialysis are at increased risk of TB and may be more likely to experience unfavourable treatment outcomes. Evidence on this association remains limited in Brazil, particularly in high-burden settings characterized by geographic barriers and challenges in access to specialized healthcare services. We assessed the association between MD and unfavourable TB treatment outcomes in Amazonas, Brazil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective population-based cohort study including all new TB cases reported in Amazonas, Brazil, between 2001 and 2023. Probabilistic record linkage was performed between the state TB surveillance system (SINAN-TB) and a dialysis registry to identify patients receiving MD before TB diagnosis. The primary exposure was MD prior to TB diagnosis. Unfavourable outcomes comprised death from any cause, loss to follow-up, or treatment failure. Multivariable logistic regression was used to estimate adjusted odds ratios (aORs) with 95% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 58,611\u00a0TB cases included in the analysis, 112 (0.2%) had evidence of MD before TB diagnosis. MD was strongly associated with higher odds of unfavourable outcomes (aOR 5.45; 95% CI 3.60\u20138.24). Illicit drug use (aOR 2.18; 95% CI 1.97\u20132.40), HIV\/AIDS (aOR 2.06; 95% CI 1.94\u20132.19), mental illness (aOR 1.53; 95% CI 1.27\u20131.83), alcohol use (aOR 1.38; 95% CI 1.29\u20131.48), and smoking (aOR 1.30; 95% CI 1.20\u20131.42) were also associated with increased odds of unfavourable outcomes. In contrast, directly observed therapy (DOT) (aOR 0.67; 95% CI 0.63\u20130.71), female sex (aOR 0.82; 95% CI 0.79\u20130.85), and diabetes mellitus (aOR 0.84; 95% CI 0.78\u20130.91) were associated with reduced odds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Within a large population-based TB cohort, MD was a rare but clinically important exposure that was strongly associated with unfavourable treatment outcomes. The protective effect of DOT highlights a feasible intervention pathway. These findings support the integration of TB care into dialysis services and reinforce the need to prioritize this population for targeted TB screening and preventive strategies in high-burden settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13991-3","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:05:16Z","timestamp":1783929916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between maintenance dialysis and tuberculosis treatment outcomes in Amazonas, Brazil: a population-based record-linkage cohort study (2001\u20132023)"],"prefix":"10.1186","volume":"26","author":[{"given":"Samanta Samara Bicharra","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djane Clarys","family":"Baia-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair","family":"dos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Sousa","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Spener-Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara Bezerra","family":"de Oliveira de Assis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Bonif\u00e1cio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brige","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Barreto-Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moreno M. S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno B.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Carvalho","family":"de Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Cordeiro-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"13991_CR1","unstructured":"World Health Organization. Global tuberculosis report 2025 [Internet]. Geneva: World Health Organization. 2025 [cited 2026 Jun 11]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240116924."},{"issue":"Suppl 1","key":"13991_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12963-020-00203-6","volume":"18","author":"FR Martins-Melo","year":"2020","unstructured":"Martins-Melo FR, Bezerra JMT, Barbosa DS, Carneiro M, Andrade KB, Ribeiro ALP, et al. The burden of tuberculosis and attributable risk factors in Brazil, 1990\u20132017: results from the Global Burden of Disease Study 2017. Popul Health Metr. 2020;18(Suppl 1):10. https:\/\/doi.org\/10.1186\/s12963-020-00203-6.","journal-title":"Popul Health Metr"},{"key":"13991_CR3","doi-asserted-by":"publisher","first-page":"e1380","DOI":"10.1016\/S2214-109X(21)00300-4","volume":"9","author":"L Chenciner","year":"2021","unstructured":"Chenciner L, Annerstedt KS, Pescarini JM, Wingfield T. Social and health factors associated with unfavourable treatment outcome in adolescents and young adults with tuberculosis in Brazil: a national retrospective cohort study. Lancet Glob Health. 2021;9:e1380\u201390. https:\/\/doi.org\/10.1016\/S2214-109X(21)00300-4.","journal-title":"Lancet Glob Health"},{"key":"13991_CR4","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade e Ambiente. Boletim epidemiol\u00f3gico de tuberculose: n\u00famero especial [Internet]. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2024 [cited 2025 Mar 18]. Available from: https:\/\/www.gov.br\/saude\/pt-br\/centrais-de-conteudo\/publicacoes\/boletins\/epidemiologicos\/especiais\/2024\/boletim-epidemiologico-de-tuberculose-numero-especial-mar-2024.pdf."},{"key":"13991_CR5","doi-asserted-by":"publisher","first-page":"e0158574","DOI":"10.1371\/journal.pone.0158574","volume":"11","author":"DB De Castro","year":"2016","unstructured":"De Castro DB, Pinto RC, De Albuquerque BC, Sadahiro M, Braga JU. The socioeconomic factors and the indigenous component of tuberculosis in Amazonas. PLoS ONE. 2016;11:e0158574. https:\/\/doi.org\/10.1371\/journal.pone.0158574.","journal-title":"PLoS ONE"},{"key":"13991_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijid.2022.05.046","volume":"122","author":"A Alemu","year":"2022","unstructured":"Alemu A, Bitew ZW, Diriba G, Seid G, Eshetu K, Chekol MT, et al. Tuberculosis incidence in patients with chronic kidney disease: a systematic review and meta-analysis. Int J Infect Dis. 2022;122:188\u2013201. https:\/\/doi.org\/10.1016\/j.ijid.2022.05.046.","journal-title":"Int J Infect Dis"},{"key":"13991_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.kint.2016.01.034","volume":"90","author":"K Romanowski","year":"2016","unstructured":"Romanowski K, Clark EG, Levin A, Cook VJ, Johnston JC. Tuberculosis and chronic kidney disease: an emerging global syndemic. Kidney Int. 2016;90:34\u201340. https:\/\/doi.org\/10.1016\/j.kint.2016.01.034.","journal-title":"Kidney Int"},{"key":"13991_CR8","doi-asserted-by":"publisher","first-page":"6533","DOI":"10.3390\/jcm14186533","volume":"14","author":"RM Alhamawi","year":"2025","unstructured":"Alhamawi RM, Shafea BY, Bakhsh HH, Fayraq LA, Aloufi ST, Alharbi TF, et al. The impact of hemodialysis on humoral and cellular immunity in patients with renal failure. J Clin Med. 2025;14:6533. https:\/\/doi.org\/10.3390\/jcm14186533.","journal-title":"J Clin Med"},{"key":"13991_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/nu10010069","volume":"10","author":"M Maraj","year":"2018","unstructured":"Maraj M, Ku\u015bnierz-Cabala B, Dumnicka P, Gala-B\u0142\u0105dzi\u0144ska A, Gawlik K, Pawlica-Gosiewska D, et al. Malnutrition, inflammation, atherosclerosis syndrome (MIA) and diet recommendations among end-stage renal disease patients treated with maintenance hemodialysis. Nutrients. 2018;10:69. https:\/\/doi.org\/10.3390\/nu10010069.","journal-title":"Nutrients"},{"key":"13991_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/ckj\/sfac196","volume":"16","author":"IW Wu","year":"2023","unstructured":"Wu IW, Wu YL, Yang HY, Hsu CK, Chang LC, Twu YC, et al. Deep immune profiling of patients with renal impairment unveils distinct immunotypes associated with disease severity. Clin Kidney J. 2023;16:78\u201389. https:\/\/doi.org\/10.1093\/ckj\/sfac196.","journal-title":"Clin Kidney J"},{"key":"13991_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/life13040860","volume":"13","author":"DV Daikidou","year":"2023","unstructured":"Daikidou DV, Lioulios G, Sampani E, Xochelli A, Nikolaidou V, Moysidou E, et al. Prospective analysis of B lymphocyte subtypes before and after initiation of dialysis in patients with end-stage renal disease. Life (Basel). 2023;13:860. https:\/\/doi.org\/10.3390\/life13040860.","journal-title":"Life (Basel)"},{"key":"13991_CR12","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.3390\/jcm12216911","volume":"12","author":"A Kawalec","year":"2023","unstructured":"Kawalec A, Stojanowski J, Mazurkiewicz P, Choma A, Gaik M, Pluta M, et al. Systemic immune inflammation index as a key predictor of dialysis in pediatric chronic kidney disease with the use of random forest classifier. J Clin Med. 2023;12:6911. https:\/\/doi.org\/10.3390\/jcm12216911.","journal-title":"J Clin Med"},{"key":"13991_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/08860220903367528","volume":"32","author":"G Ates","year":"2010","unstructured":"Ates G, Yildiz T, Danis R, Akyildiz L, Erturk B, Beyazit H, et al. Incidence of tuberculosis disease and latent tuberculosis infection in patients with end-stage renal disease in an endemic region. Ren Fail. 2010;32:91\u20135. https:\/\/doi.org\/10.3109\/08860220903367528.","journal-title":"Ren Fail"},{"key":"13991_CR14","doi-asserted-by":"publisher","first-page":"100302","DOI":"10.1016\/j.jctube.2022.100302","volume":"27","author":"R Bandiara","year":"2022","unstructured":"Bandiara R, Indrasari A, Dewi Rengganis A, Sukesi L, Afiatin A, Santoso P. Risk factors of latent tuberculosis among chronic kidney disease with routine haemodialysis patients. J Clin Tuberc Other Mycobact Dis. 2022;27:100302. https:\/\/doi.org\/10.1016\/j.jctube.2022.100302.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"13991_CR15","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.5588\/ijtld.15.0081","volume":"19","author":"K Al-Efraij","year":"2015","unstructured":"Al-Efraij K, Mota L, Lunny C, Schachter M, Cook V, Johnston J. Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2015;19:1493\u20139. https:\/\/doi.org\/10.5588\/ijtld.15.0081.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"13991_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1590\/S1806-37132013000500009","volume":"39","author":"B Reis-Santos","year":"2013","unstructured":"Reis-Santos B, Gomes T, Horta BL, Maciel ELN. The outcome of tuberculosis treatment in subjects with chronic kidney disease in Brazil: a multinomial analysis. J Bras Pneumol. 2013;39(5):585\u201394.","journal-title":"J Bras Pneumol"},{"key":"13991_CR17","volume-title":"Manual de recomenda\u00e7\u00f5es e controle da tuberculose no Brasil","author":"Brasil","year":"2024","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade e Ambiente. Departamento de HIV\/Aids, Tuberculose, Hepatites Virais e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis. Manual de recomenda\u00e7\u00f5es e controle da tuberculose no Brasil. 2 ed. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2024.","edition":"2"},{"key":"13991_CR18","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2019. Available from: https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_recomendacoes_controle_tuberculose_brasil.pdf."},{"key":"13991_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/hdi.12693","volume":"23","author":"S Vikrant","year":"2019","unstructured":"Vikrant S. Tuberculosis in dialysis: clinical spectrum and outcome from an endemic region. Hemodial Int. 2019;23:88\u201392. https:\/\/doi.org\/10.1111\/hdi.12693.","journal-title":"Hemodial Int"},{"key":"13991_CR20","doi-asserted-by":"publisher","unstructured":"Xiao J, Ge J, Zhang D, Lin X, Wang X, Peng L et al. Clinical characteristics and outcomes in chronic kidney disease patients with tuberculosis in China: a retrospective cohort study. Int J Gen Med. 2022;15:6661\u20136670. https:\/\/doi.org\/10.2147\/IJGM.S367090.","DOI":"10.2147\/IJGM.S367090"},{"key":"13991_CR21","doi-asserted-by":"publisher","first-page":"e0320907","DOI":"10.1371\/journal.pone.0320907","volume":"20","author":"SK Dodani","year":"2025","unstructured":"Dodani SK, Babar ZU, Mohammad KG, Ali S, Mushtaq M, Batool S, et al. Clinical presentation and outcome of tuberculosis in chronic kidney disease stage 4 & 5 from a high TB burden country. PLoS ONE. 2025;20:e0320907. https:\/\/doi.org\/10.1371\/journal.pone.0320907.","journal-title":"PLoS ONE"},{"key":"13991_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/IJNRD.S450565","volume":"17","author":"E Beyene","year":"2024","unstructured":"Beyene E, Demissie Z, Jote WT, Getachew S, Ejigu AM, Degu WA. Burden of tuberculosis in end stage renal disease patients undergoing maintenance hemodialysis: a multicenter study and experience from Ethiopian dialysis setting. Int J Nephrol Renovasc Dis. 2024;17:59\u201369. https:\/\/doi.org\/10.2147\/IJNRD.S450565.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"8","key":"13991_CR23","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/cid\/ciad364","volume":"77","author":"P Luczynski","year":"2023","unstructured":"Luczynski P, Holmes T, Romanowski K, Arbiv OA, Cook VJ, Clark EG, et al. Risk of tuberculosis disease in people with chronic kidney disease without kidney failure: a systematic review and meta-analysis. Clin Infect Dis. 2023;77(8):1194\u2013200. https:\/\/doi.org\/10.1093\/cid\/ciad364.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"13991_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0002-9343(80)90166-7","volume":"68","author":"OT Andrew","year":"1980","unstructured":"Andrew OT, Schoenfeld PY, Hopewell PC, Humphreys MH. Tuberculosis in patients with end-stage renal disease. Am J Med. 1980;68(1):59\u201365. https:\/\/doi.org\/10.1016\/0002-9343(80)90166-7.","journal-title":"Am J Med"},{"issue":"39","key":"13991_CR25","doi-asserted-by":"publisher","first-page":"e12550","DOI":"10.1097\/MD.0000000000012550","volume":"97","author":"KC Cheng","year":"2018","unstructured":"Cheng KC, Liao KF, Lin CL, Liu CS, Lai SW. Chronic kidney disease correlates with increased risk of pulmonary tuberculosis before initiating renal replacement therapy: a cohort study in Taiwan. Med (Baltim). 2018;97(39):e12550. https:\/\/doi.org\/10.1097\/MD.0000000000012550.","journal-title":"Med (Baltim)"},{"issue":"11","key":"13991_CR26","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1017\/ice.2018.219","volume":"39","author":"RC Okada","year":"2018","unstructured":"Okada RC, Barry PM, Skarbinski J, Chitnis AS. Epidemiology, detection, and management of tuberculosis among end-stage renal disease patients. Infect Control Hosp Epidemiol. 2018;39(11):1367\u201374. https:\/\/doi.org\/10.1017\/ice.2018.219.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"13991_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/08860220802064721","volume":"30","author":"H Kayabasi","year":"2008","unstructured":"Kayabasi H, Sit D, Kadiroglu AK, Kara IH, Yilmaz ME. The prevalence and the characteristics of tuberculosis patients undergoing chronic dialysis treatment: experience of a dialysis center in Southeast Turkey. Ren Fail. 2008;30(5):513\u20139. https:\/\/doi.org\/10.1080\/08860220802064721.","journal-title":"Ren Fail"},{"issue":"10","key":"13991_CR28","doi-asserted-by":"publisher","first-page":"e30369","DOI":"10.7759\/cureus.30369","volume":"14","author":"G El Bardai","year":"2022","unstructured":"El Bardai G, Kabbali N, Baba H, Chouhani BA, Houssaini TS. Tuberculosis in dialysis patients in the Central Region of Morocco: what is the health-care delay? Cureus. 2022;14(10):e30369. https:\/\/doi.org\/10.7759\/cureus.30369.","journal-title":"Cureus"},{"issue":"2","key":"13991_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4274\/ThoracResPract.2026.2025-10-8","volume":"27","author":"B \u00c7il","year":"2026","unstructured":"\u00c7il B, Bodur MS, Kabak M. Underutilization of bacteriological testing in extrapulmonary tuberculosis: a retrospective single-center study from Mardin, T\u00fcrkiye. Thorac Res Pract. 2026;27(2):109\u201313. https:\/\/doi.org\/10.4274\/ThoracResPract.2026.2025-10-8.","journal-title":"Thorac Res Pract"},{"key":"13991_CR30","doi-asserted-by":"publisher","first-page":"103251","DOI":"10.1016\/j.eclinm.2025.103251","volume":"84","author":"B Freitag","year":"2025","unstructured":"Freitag B, Sultanli A, Grilli M, Weber SF, Gaeddert M, Abdullahi OA, et al. Clinically diagnosed tuberculosis and mortality in high burden settings: a systematic review and meta-analysis. EClinicalMedicine. 2025;84:103251. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103251.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"13991_CR31","doi-asserted-by":"publisher","first-page":"e2019017","DOI":"10.5123\/S1679-49742020000100009","volume":"29","author":"MS Rocha","year":"2020","unstructured":"Rocha MS, Bartholomay P, Cavalcante MV, Medeiros FC, Codenotti SB, Pelissari DM, et al. Notifiable Diseases Information System (SINAN): main features of tuberculosis notification and data analysis. Epidemiol Serv Saude. 2020;29(1):e2019017. https:\/\/doi.org\/10.5123\/S1679-49742020000100009.","journal-title":"Epidemiol Serv Saude"},{"issue":"1","key":"13991_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1631\/jzus.B1200244","volume":"14","author":"WF Yang","year":"2013","unstructured":"Yang WF, Han F, Zhang XH, Zhang P, Chen JH. Extra-pulmonary tuberculosis infection in the dialysis patients with end stage renal diseases: case reports and literature review. J Zhejiang Univ Sci B. 2013;14(1):76\u201382. https:\/\/doi.org\/10.1631\/jzus.B1200244.","journal-title":"J Zhejiang Univ Sci B"},{"key":"13991_CR33","doi-asserted-by":"publisher","unstructured":"Babar ZU, Dodani SK, Nasim A, Badlani SK. 1867. Clinical presentation and outcome of tuberculosis in patients with chronic kidney disease stage 4 and 5: a retrospective cohort study from a TB endemic country. Open Forum Infect Dis. 2023;10(2):ofad500.1695. https:\/\/doi.org\/10.1093\/ofid\/ofad500.1695.","DOI":"10.1093\/ofid\/ofad500.1695"},{"key":"13991_CR34","doi-asserted-by":"publisher","first-page":"7401541","DOI":"10.1155\/2020\/7401541","volume":"2020","author":"RR Pradhan","year":"2020","unstructured":"Pradhan RR, Sigdel MR. Prevalence, clinical presentation, and outcome of tuberculosis in patients with chronic kidney disease at a tertiary care hospital in Nepal. Int J Nephrol. 2020;2020:7401541. https:\/\/doi.org\/10.1155\/2020\/7401541.","journal-title":"Int J Nephrol"},{"issue":"2","key":"13991_CR35","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4103\/1319-2442.256854","volume":"30","author":"S Vikrant","year":"2019","unstructured":"Vikrant S. Clinical profile of tuberculosis in patients with chronic kidney disease: a report from an endemic country. Saudi J Kidney Dis Transpl. 2019;30(2):470\u20137. https:\/\/doi.org\/10.4103\/1319-2442.256854.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"3","key":"13991_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/hdi.13010","volume":"26","author":"M Ali","year":"2022","unstructured":"Ali M, Dosani D, Corbett R, Johansson L, Charif R, Kon OM, et al. Diagnosis of tuberculosis in dialysis and kidney transplant patients. Hemodial Int. 2022;26(3):361\u20138. https:\/\/doi.org\/10.1111\/hdi.13010.","journal-title":"Hemodial Int"},{"issue":"1","key":"13991_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12931-020-1294-5","volume":"21","author":"CC Shu","year":"2020","unstructured":"Shu CC, Wei YF, Yeh YC, Lin HH, Chen CY, Wang PH, et al. The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship. Respir Res. 2020;21(1):51. https:\/\/doi.org\/10.1186\/s12931-020-1294-5.","journal-title":"Respir Res"},{"issue":"3","key":"13991_CR38","doi-asserted-by":"publisher","first-page":"e36833","DOI":"10.7759\/cureus.36833","volume":"15","author":"GN Hernandez","year":"2023","unstructured":"Hernandez GN, Seffah K, Zaman MA, Awais N, Satnarine T, Haq A, et al. Unraveling the secrets behind the multidrug-resistant tuberculosis treatment outcome in chronic renal failure patients requiring hemodialysis: a systematic review. Cureus. 2023;15(3):e36833. https:\/\/doi.org\/10.7759\/cureus.36833.","journal-title":"Cureus"},{"issue":"20","key":"13991_CR39","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.3390\/nu14204297","volume":"14","author":"F Graterol Torres","year":"2022","unstructured":"Graterol Torres F, Molina M, Soler-Majoral J, Romero-Gonz\u00e1lez G, Rodr\u00edguez Chitiva N, Troya-Saborido M, et al. Evolving concepts on inflammatory biomarkers and malnutrition in chronic kidney disease. Nutrients. 2022;14(20):4297. https:\/\/doi.org\/10.3390\/nu14204297.","journal-title":"Nutrients"},{"issue":"Suppl 3","key":"13991_CR40","doi-asserted-by":"publisher","first-page":"iii35","DOI":"10.1093\/ndt\/gfy175","volume":"33","author":"G Cobo","year":"2018","unstructured":"Cobo G, Lindholm B, Stenvinkel P. Chronic inflammation in end-stage renal disease and dialysis. Nephrol Dial Transpl. 2018;33(Suppl 3):iii35\u201340. https:\/\/doi.org\/10.1093\/ndt\/gfy175.","journal-title":"Nephrol Dial Transpl"},{"key":"13991_CR41","doi-asserted-by":"publisher","first-page":"1526090","DOI":"10.3389\/fmed.2025.1526090","volume":"12","author":"V Boima","year":"2025","unstructured":"Boima V, Agyekum AB, Ganatra K, Agyekum F, Kwakyi E, Inusah J, et al. Advances in kidney disease: pathogenesis and therapeutic targets. Front Med (Lausanne). 2025;12:1526090. https:\/\/doi.org\/10.3389\/fmed.2025.1526090.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"13991_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15850\/ijihs.v9n1.2370","volume":"9","author":"R Bandiara","year":"2021","unstructured":"Bandiara R, Sukesi L, Indrasari A, Rakhimullah AB, Afiatin, Santoso P. Association between malnutrition inflammation score and latent tuberculosis among chronic hemodialysis patients. Int J Integr Health Sci. 2021;9(1):19\u201324. https:\/\/doi.org\/10.15850\/ijihs.v9n1.2370.","journal-title":"Int J Integr Health Sci"},{"key":"13991_CR43","doi-asserted-by":"publisher","first-page":"715010","DOI":"10.3389\/fmed.2021.715010","volume":"8","author":"CH Li","year":"2021","unstructured":"Li CH, Chen HJ, Chen WC, Tu CY, Hsia TC, Hsu WH, et al. The risk of tuberculosis infection in non-dialysis chronic kidney disease patients. Front Med (Lausanne). 2021;8:715010. https:\/\/doi.org\/10.3389\/fmed.2021.715010.","journal-title":"Front Med (Lausanne)"},{"key":"13991_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41533-020-0179-x","volume":"30","author":"IS Pradipta","year":"2020","unstructured":"Pradipta IS, Houtsma D, van Boven JFM, Alffenaar JWC, Hak E. Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies. NPJ Prim Care Respir Med. 2020;30:21. https:\/\/doi.org\/10.1038\/s41533-020-0179-x.","journal-title":"NPJ Prim Care Respir Med"},{"issue":"1","key":"13991_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/cid\/cit167","volume":"57","author":"JG Pasipanodya","year":"2013","unstructured":"Pasipanodya JG, Gumbo T. A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients. Clin Infect Dis. 2013;57(1):21\u201331. https:\/\/doi.org\/10.1093\/cid\/cit167.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"13991_CR46","doi-asserted-by":"publisher","first-page":"e1002595","DOI":"10.1371\/journal.pmed.1002595","volume":"15","author":"N Alipanah","year":"2018","unstructured":"Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, et al. Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018;15(7):e1002595. https:\/\/doi.org\/10.1371\/journal.pmed.1002595.","journal-title":"PLoS Med"},{"issue":"2","key":"13991_CR47","doi-asserted-by":"publisher","first-page":"e0147744","DOI":"10.1371\/journal.pone.0147744","volume":"11","author":"H Zhang","year":"2016","unstructured":"Zhang H, Ehiri J, Yang H, Tang S, Li Y. Impact of community-based DOT on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS ONE. 2016;11(2):e0147744. https:\/\/doi.org\/10.1371\/journal.pone.0147744.","journal-title":"PLoS ONE"},{"issue":"3","key":"13991_CR48","doi-asserted-by":"publisher","first-page":"e0150511","DOI":"10.1371\/journal.pone.0150511","volume":"11","author":"J Yin","year":"2016","unstructured":"Yin J, Yuan J, Hu Y, Wei X. Association between directly observed therapy and treatment outcomes in multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS ONE. 2016;11(3):e0150511. https:\/\/doi.org\/10.1371\/journal.pone.0150511.","journal-title":"PLoS ONE"},{"key":"13991_CR49","doi-asserted-by":"publisher","first-page":"102745","DOI":"10.1016\/j.eclinm.2024.102745","volume":"75","author":"S Charalambous","year":"2024","unstructured":"Charalambous S, Maraba N, Jennings L, Rabothata I, Cogill D, Mukora R, et al. Treatment adherence and clinical outcomes amongst people with drug-susceptible tuberculosis using medication monitor and differentiated care approach compared with standard of care in South Africa: a cluster randomised trial. EClinicalMedicine. 2024;75:102745. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102745.","journal-title":"EClinicalMedicine"},{"key":"13991_CR50","doi-asserted-by":"publisher","first-page":"e068685","DOI":"10.1136\/bmjopen-2022-068685","volume":"13","author":"D Jerene","year":"2023","unstructured":"Jerene D, Levy J, van Kalmthout K, van Rest J, McQuaid CF, Quaife M, et al. Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol. BMJ Open. 2023;13:e068685. https:\/\/doi.org\/10.1136\/bmjopen-2022-068685.","journal-title":"BMJ Open"},{"key":"13991_CR51","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.3390\/ijerph20176670","volume":"20","author":"SG Mpagama","year":"2023","unstructured":"Mpagama SG, Byashalira KC, Chamba NG, Heysell SK, Alimohamed MZ, Shayo PJ, et al. Implementing innovative approaches to improve health care delivery systems for integrating communicable and non-communicable diseases using tuberculosis and diabetes as a model in Tanzania. Int J Environ Res Public Health. 2023;20:6670. https:\/\/doi.org\/10.3390\/ijerph20176670.","journal-title":"Int J Environ Res Public Health"},{"key":"13991_CR52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/S12879-021-07017-3","volume":"22","author":"JLZ Nyirenda","year":"2022","unstructured":"Nyirenda JLZ, Wagner D, Ngwira B, Lange B. Bidirectional screening and treatment outcomes of diabetes mellitus and tuberculosis patients in hospitals with measures to integrate care of diabetes and tuberculosis and those without integration measures in Malawi. BMC Infect Dis. 2022;22:28. https:\/\/doi.org\/10.1186\/S12879-021-07017-3.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"13991_CR53","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/tmi.14140","volume":"30","author":"M Zahid","year":"2025","unstructured":"Zahid M, Afaq S, Shafique K, Qazi FK, Ashfaq U, Asim M, et al. Effect of glycemic control on tuberculosis treatment outcomes among patients with tuberculosis and diabetes mellitus: a systematic review and meta-analysis. Trop Med Int Health. 2025;30(7):749\u201362. https:\/\/doi.org\/10.1111\/tmi.14140.","journal-title":"Trop Med Int Health"},{"issue":"7","key":"13991_CR54","doi-asserted-by":"publisher","first-page":"783","DOI":"10.5588\/ijtld.18.0433","volume":"23","author":"P Huangfu","year":"2019","unstructured":"Huangfu P, Ugarte-Gil C, Golub J, Pearson F, Critchley J. The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. Int J Tuberc Lung Dis. 2019;23(7):783\u201396. https:\/\/doi.org\/10.5588\/ijtld.18.0433.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13991_CR55","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/S12879-023-08765-0","volume":"23","author":"G Xu","year":"2023","unstructured":"Xu G, Hu X, Lian Y, Li X. Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2023;23:813. https:\/\/doi.org\/10.1186\/S12879-023-08765-0.","journal-title":"BMC Infect Dis"},{"key":"13991_CR56","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1038\/s41598-021-81057-2","volume":"11","author":"S Gautam","year":"2021","unstructured":"Gautam S, Shrestha N, Mahato S, Nguyen TPA, Mishra SR, Berg-Beckhoff G. Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis. Sci Rep. 2021;11:2113. https:\/\/doi.org\/10.1038\/s41598-021-81057-2.","journal-title":"Sci Rep"},{"issue":"11","key":"13991_CR57","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.5588\/ijtld.17.0211","volume":"21","author":"P Huangfu","year":"2017","unstructured":"Huangfu P, Pearson F, Ugarte-Gil C, Critchley J. Diabetes and poor tuberculosis treatment outcomes: issues and implications in data interpretation and analysis. Int J Tuberc Lung Dis. 2017;21(11):1214\u20139. https:\/\/doi.org\/10.5588\/ijtld.17.0211.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13991_CR58","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/healthcare11040508","volume":"11","author":"GF Costa","year":"2023","unstructured":"Costa GF, Garcez JCD, Marcos W, Ferreira ALS, Andrade JAA, Rodrigues YC, et al. Factors associated with tuberculosis outcome in a hyperendemic city in the North of Brazil. Healthc (Basel). 2023;11:508. https:\/\/doi.org\/10.3390\/healthcare11040508.","journal-title":"Healthc (Basel)"},{"key":"13991_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13690-018-0287-z","volume":"76","author":"DM Pelissari","year":"2018","unstructured":"Pelissari DM, Diaz-Quijano FA. Impact of alcohol disorder and the use of illicit drugs on tuberculosis treatment outcomes: a retrospective cohort study. Arch Public Health. 2018;76:45. https:\/\/doi.org\/10.1186\/s13690-018-0287-z.","journal-title":"Arch Public Health"},{"issue":"5","key":"13991_CR60","doi-asserted-by":"publisher","first-page":"e930","DOI":"10.1093\/cid\/ciac541","volume":"76","author":"F Ridolfi","year":"2023","unstructured":"Ridolfi F, Peetluk L, Amorim G, Turner M, Figueiredo M, Cordeiro-Santos M, et al. Tuberculosis treatment outcomes in Brazil: different predictors for each type of unsuccessful outcome. Clin Infect Dis. 2023;76(5):e930\u201340. https:\/\/doi.org\/10.1093\/cid\/ciac541.","journal-title":"Clin Infect Dis"},{"key":"13991_CR61","doi-asserted-by":"publisher","first-page":"101305","DOI":"10.1016\/j.lana.2025.101305","volume":"53","author":"B Barreto-Duarte","year":"2026","unstructured":"Barreto-Duarte B, Villalva-Serra K, Miguez-Pinto JP, Ara\u00fajo-Pereira M, Campos VMS, Ferreira IBB, et al. Interplay between biological and social vulnerability and poor tuberculosis treatment outcome in Brazil: a nationwide study using multivariate modelling with excess risk. Lancet Reg Health Am. 2026;53:101305. https:\/\/doi.org\/10.1016\/j.lana.2025.101305.","journal-title":"Lancet Reg Health Am"},{"key":"13991_CR62","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/S13690-023-01147-7","volume":"81","author":"CL Giacomet","year":"2023","unstructured":"Giacomet CL, Ramos ACV, Moura HSD, Berra TZ, Alves YM, Delpino FM, et al. A distributional regression approach to modeling the impact of structural and intermediary social determinants on communities burdened by tuberculosis in Eastern Amazonia, Brazil. Arch Public Health. 2023;81:135. https:\/\/doi.org\/10.1186\/S13690-023-01147-7.","journal-title":"Arch Public Health"},{"key":"13991_CR63","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.lana.2024.100938","volume":"40","author":"VS Santos","year":"2024","unstructured":"Santos VS, Holanda JRC, Gois-Neto RDS, Maciel ELN, Johansen FDC, Silva-J\u00fanior JNB, et al. Social and health factors associated with unfavourable treatment outcomes in children and adolescents with drug-sensitive tuberculosis in Brazil: a national retrospective cohort study. Lancet Reg Health Am. 2024;40:100938. https:\/\/doi.org\/10.1016\/j.lana.2024.100938.","journal-title":"Lancet Reg Health Am"},{"key":"13991_CR64","doi-asserted-by":"publisher","first-page":"e018822","DOI":"10.1136\/bmjgh-2024-018822","volume":"10","author":"DK Ryuk","year":"2025","unstructured":"Ryuk DK, Pelissari DM, Alves K, Harada LO, Oliveira PB, Johansen FDC, et al. Systematic differences in tuberculosis treatment outcomes across Brazil by patient- and area-related factors: an analysis of national disease registry data. BMJ Glob Health. 2025;10:e018822. https:\/\/doi.org\/10.1136\/bmjgh-2024-018822.","journal-title":"BMJ Glob Health"},{"key":"13991_CR65","doi-asserted-by":"publisher","first-page":"e223465","DOI":"10.1136\/jech-2024-223465","volume":"79","author":"Q Hall","year":"2025","unstructured":"Hall Q, de Sousa Filho JF, Guimar\u00e3es JMN, Malta DC, Romero-Sandoval NC, Hargreaves S, et al. Associations of municipality-level income and racial segregation with individual-level tuberculosis treatment outcomes in Brazil: a nationwide cohort study (2010\u20132019). J Epidemiol Community Health. 2025;79:e223465. https:\/\/doi.org\/10.1136\/jech-2024-223465.","journal-title":"J Epidemiol Community Health"},{"key":"13991_CR66","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/S12879-024-09417-7","volume":"24","author":"DK Ryuk","year":"2024","unstructured":"Ryuk DK, Pelissari DM, Alves K, Oliveira PB, Castro MC, Cohen T, et al. Predictors of unsuccessful tuberculosis treatment outcomes in Brazil: an analysis of 259,484 patient records. BMC Infect Dis. 2024;24:531. https:\/\/doi.org\/10.1186\/S12879-024-09417-7.","journal-title":"BMC Infect Dis"},{"key":"13991_CR67","doi-asserted-by":"publisher","first-page":"706689","DOI":"10.3389\/fmed.2021.706689","volume":"8","author":"B Barreto-Duarte","year":"2021","unstructured":"Barreto-Duarte B, Ara\u00fajo-Pereira M, Nogueira BMF, Sobral L, Rodrigues MMS, Queiroz ATL, et al. Tuberculosis burden and determinants of treatment outcomes according to age in Brazil: a nationwide study of 896,314 cases reported between 2010 and 2019. Front Med (Lausanne). 2021;8:706689. https:\/\/doi.org\/10.3389\/fmed.2021.706689.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"13991_CR68","doi-asserted-by":"publisher","first-page":"ofae416","DOI":"10.1093\/ofid\/ofae416","volume":"11","author":"B Barreto-Duarte","year":"2024","unstructured":"Barreto-Duarte B, Villalva-Serra K, Miguez-Pinto JP, Ara\u00fajo-Pereira M, Campos VMS, Rosier G, et al. Retreatment and anti-tuberculosis therapy outcomes in Brazil between 2015 and 2022: a nationwide study. Open Forum Infect Dis. 2024;11(8):ofae416. https:\/\/doi.org\/10.1093\/ofid\/ofae416.","journal-title":"Open Forum Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13991-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13991-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13991-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:25:44Z","timestamp":1791336344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13991-3"}},"subtitle":["Maintenance Dialysis and Tuberculosis Outcomes"],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13991"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13991-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and the Brazilian National Health Council Resolution No. 466\/2012. The study protocol was approved by the Ethics Committee of the Funda\u00e7\u00e3o de Medicina Tropical (CAAE: 74993423.8.0000.0005). The ethics committee waived the requirement for written informed consent due to the study\u2019s retrospective nature and the use of anonymized secondary data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors utilized ChatGPT (version 4, from OpenAI, San Francisco, California, USA) and Grammarly to refine and summarize the language. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the publication's content.","order":3,"name":"Ethics","label":"Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1781"}}